The potential and limits for clinical trials for early Alzheimer's disease and some recommendations
Open Access
- 1 April 2010
- journal article
- research article
- Published by Elsevier in The Journal of nutrition, health and aging
- Vol. 14 (4) , 295-298
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Current Alzheimer's disease clinical trials: Methods and placebo outcomesAlzheimer's & Dementia, 2009
- Characteristics and Performance of a Modified Version of the ADCS-CGIC CIBIC+ for Mild Cognitive Impairment Clinical TrialsAlzheimer Disease & Associated Disorders, 2009
- Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteriaThe Lancet Neurology, 2007
- Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trialNeurology, 2007
- Ten-year risk of dementia in subjects with mild cognitive impairmentNeurology, 2006
- ADCS Prevention Instrument Project: Assessment of Instrumental Activities of Daily Living for Community-dwelling Elderly Individuals in Dementia Prevention Clinical TrialsAlzheimer Disease & Associated Disorders, 2006
- Neuropathologic Outcome of Mild Cognitive Impairment Following Progression to Clinical DementiaArchives of Neurology, 2006
- Vitamin E and Donepezil for the Treatment of Mild Cognitive ImpairmentNew England Journal of Medicine, 2005
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- “Mini-mental state”Journal of Psychiatric Research, 1975